Home » Authors » Donna Young

Donna Young

Articles

ARTICLES

Amgen's Woes Disrupt Plans For $1 Billion Plant In Ireland

Oct. 5, 2007

Amgen's Woes Disrupt Plans For $1 Billion Plant In Ireland

Oct. 5, 2007

Alethia, Canadian Agency In Deal For Cancer Targeting

Oct. 4, 2007

Alethia Biotherapeutics Inc. has entered into a licensing agreement with Canada's National Research Council Biotechnology Research Institute (NRC-BRI) for the worldwide therapeutic and diagnostic rights to Clusterin-specific antibodies. (BioWorld Today)

Alethia, Canadian Agency In Deal For Cancer Targeting

Oct. 4, 2007

Alethia Biotherapeutics Inc. has entered into a licensing agreement with Canada's National Research Council Biotechnology Research Institute (NRC-BRI) for the worldwide therapeutic and diagnostic rights to Clusterin-specific antibodies. (BioWorld Today)

Axcan, Cellerix Deal For Adult Stem Cell Therapy

Oct. 3, 2007

Axcan, Cellerix Deal For Adult Stem Cell Therapy

Oct. 3, 2007

House Passes Bill Called Vital to Free SBIR Money for Biotech

Oct. 2, 2007

Theratechnologies Reports Strong Results For TH9507

Oct. 2, 2007

Theratechnologies Reports Strong Results For TH9507

Oct. 2, 2007

House Passes Bill Called Vital to Free SBIR Money for Biotech

Oct. 2, 2007

View All Articles by Donna Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...